Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.007.24%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.69% | 23.98% | 66.99% | 145.42% | 52.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.69% | 23.98% | 66.99% | 145.42% | 52.49% |
| Cost of Revenue | 183.86% | 49.29% | 69.52% | 193.47% | 21.73% |
| Gross Profit | -32.86% | 11.18% | 65.89% | 125.44% | 65.91% |
| SG&A Expenses | 33.22% | 16.76% | 31.83% | 32.78% | 49.67% |
| Depreciation & Amortization | -14.30% | -33.98% | -32.38% | -128.69% | -10.03% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.23% | 21.29% | 36.77% | 50.71% | 33.87% |
| Operating Income | -1,921.65% | -10.12% | 265.04% | 388.19% | 131.73% |
| Income Before Tax | -390.78% | 37.12% | 61.24% | -149.30% | 84.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -390.78% | 37.12% | 61.24% | -149.30% | 84.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -390.78% | 37.12% | 61.24% | -149.30% | 84.85% |
| EBIT | -1,921.65% | -10.12% | 265.04% | 388.19% | 131.73% |
| EBITDA | -408.04% | -44.06% | 3,624.53% | 1,320.33% | 332.05% |
| EPS Basic | -390.40% | 37.36% | 61.40% | -147.09% | 84.96% |
| Normalized Basic EPS | -344.12% | 37.34% | 61.37% | 64.11% | 49.20% |
| EPS Diluted | -390.40% | 37.36% | 61.40% | -147.09% | 84.96% |
| Normalized Diluted EPS | -344.12% | 37.34% | 61.37% | 64.11% | 49.20% |
| Average Basic Shares Outstanding | 0.00% | 0.36% | 0.36% | 0.66% | 0.76% |
| Average Diluted Shares Outstanding | 0.00% | 0.36% | 0.36% | 0.66% | 0.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |